Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-α gene and their associations with multiple sclerosis

European Journal of Human Genetics

Volumn 11, Issue 7, 2003, Pages 509-515

  Teutsch, Suzy M ^a,b   Booth, David R ^a,b   Bennetts, Bruce H ^c   Heard, Robert N S ^a,b   Stewart, Graeme J ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Haplotype; Interleukin 7 receptor ; Multiple sclerosis; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 7 RECEPTOR; ISOLEUCINE; RECEPTOR SUBTYPE; THREONINE; VALINE;

3' UNTRANSLATED REGION; ALLELE; ALPHA CHAIN; AMINO ACID SUBSTITUTION; ARTICLE; B LYMPHOCYTE; CHROMOSOME 12P; CHROMOSOME 5P; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE POOL; GENETIC ASSOCIATION; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INTRON; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM;

AUSTRALIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HUMANS; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RECEPTORS, INTERLEUKIN-7;

EID: 0041808918     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200994     Document Type: Article

References (31)

1. Dyment DA, Sadnovich AD, Ebers GC: Genetics of multiple sclerosis. Hum Mol Genet 1997; 6: 1693-1698.
2. Sawcer S, Jones H, Feakes R et al: A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996; 13: 464-468.
3. Haines J, Pericak-Vance M, Seboun E, Hauser S, the Multiple Sclerosis Genetics Group: A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996; 13: 469-471.
4. Ebers GC, Kukay K, Bulman DE et al: A full genome search in multiple sclerosis. Nat Genet 1996; 13: 472-480.
5. Kuokkanen S, Gschwend M, Rioux JD et al: Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997; 61: 1379-1387.
6. Broadley S, Sawcer S, D'Alfonso S et al: A genome screen for multiple sclerosis in Italian families. Genes Immun 2001; 2: 205-210.
7. Coraddu F, Sawcer S, D'Alfonso S et al: A genome screen for multiple sclerosis in Sardinian multiplex families. Eur J Hum Genet 2001; 9: 621-626.
8. Stewart GJ: Multiple sclerosis, multiple genes. Med J Aust 1997; 166: 573-574.
9. Oturai A, Larsen F, Ryder LP et al: Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann Neurol 1999; 46: 612-616.
10. Sundvall M, Jirholt J, Yang HT et al: Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet 1995; 10: 313-317.
11. Kuokkanen S, Sundvall M, Terwilliger JD et al: A putative vulnerability locus to multiple sclerosis in a region syntenic to the murine locus Eae2. Nat Genet 1996; 13: 477-480.
12. Chataway J, Sawcer S, Sherman D et al: No evidence for association of multiple sclerosis with the complement factors C6 and C7. J Neuroimmunol 1999; 99: 150-156.
13. Pleiman CM, Gimpel SD, Park LS, Harada H, Taniguchi T, Ziegler SF: Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon-inducible promoter. Mol Cell Biol 1991; 11: 3052-3059.
14. Plum J, De Smedt M, Leclercq G, Verhasselt B, Vandekerckhove B: Interleukin-7 is a critical growth factor in early human T-cell development. Blood 1996; 88: 4239-4245.
15. Ziegler SF, Morella KK, Anderson D et al: Reconstitution of a functional interleukin (IL)-7 receptor demonstrates that the IL-2 receptor γ chain is required for IL-7 signal transduction. Eur J Immunol 1995; 25: 399-404.
16. Chou YK, Bourdette DN, Barnes D et al: IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R α and γ chains. J Neuroimmunol 1999; 96: 101-111.
17. Traggiai E, Biagioli T, Rosati E et al: IL-7 enhanced T-cell response to myelin proteins in multiple sclerosis. J Neuroimmunol 2001; 121: 111-119.
18. Bebo Jr BF, Shuster JC, Adlard K, Vandenbark AA, Offner H: Interleukin 7 is a potent co-stimulator of myelin specific T cells that enhances the adoptive transfer of experimental autoimmune encephalomyelitis. Cytokine 2000; 12: 324-331.
19. Ramanathan M, Weinstock-Guttman B, Nguyen LT et al: In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J Neuroimmunol 2001; 116: 213-219.
20. Johnson GC, Esposito L, Barratt BJ et al: Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-237.
21. Tabor HK, Risch NJ, Myers RM: OPINION: candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002; 3: 391-397.
22. Poser CM, Sheinberg L, McDonald WI et al: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
23. Barcellos LF, Klitz W, Field LL et al: Association mapping of disease loci, by use of a pooled DNA genomic screen. Am J Hum Genet 1997; 61: 734-747.
24. Puel A, Ziegler SF, Buckley RH, Leonard WJ: Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20: 394-397.
25. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitis (IDDM). Am J Hum Genet 1993; 52: 506-516.
26. Wingender E, Chen X, Hehl R et al: TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 2000; 28: 316-319.
27. Roifman CM, Zhang J, Chitayat D, Scharfe N: A partial deficiency of interleukin-7Rα is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood 2000; 15: 2803-2807.
28. Giordano M, Oefner PJ, Underhill PA, Cavali Sforza LL, Tosi R, Momigliano Richiardi P: Identification by denaturing high-performance liquid chromatography of numerous polymorphisms in a candidate region for multiple sclerosis susceptibility. Genomics 1999; 56: 247-253.
29. Mitchison NA: Polymorphism in regulatory gene sequences. Genome Biol 2001; 2: 1-6.
30. Hull J, Ackerman H, Isles K et al: Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet 2001; 69: 413-419.
31. Coraddu F, Sawcer S, Feakes R et al: HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 1998; 2: 24-33.